Mi. Shevell et al., CEREBRAL DYSGENESIS AND LACTIC ACIDEMIA - AN MRI MRS PHENOTYPE ASSOCIATED WITH PYRUVATE-DEHYDROGENASE DEFICIENCY/, Pediatric neurology, 11(3), 1994, pp. 224-229
Pyruvate dehydrogenase complex (PDHC) is an intramitochondrial multien
zyme complex essential for the aerobic oxidation of glucose. The major
ity of patients with PDHC deficiency have abnormalities in the major c
atalytic and regulatory subunit, E1 alpha, which is encoded on the X c
hromosome. The clinical spectrum of PDHC deficiency is heterogeneous,
particularly in heterozygous females, and diagnosis may be difficult.
Three affected infant girls with PDHC deficiency were investigated. Al
l had dysmorphic features, microcephaly with profound global developme
ntal delay, and hypotonia. Systemic acidosis was absent, although seru
m lactate and pyruvate were abnormally elevated. Magnetic resonance im
aging revealed hypoplasia of the corpus callosum in all patients. Prot
on magnetic resonance spectroscopy of brain revealed large increases i
n relative signal intensities for lactic acid and decreases in the rel
ative signal intensities of N-acetylaspartate, a marker of neuronal da
mage or loss. Phosphorus MRS of muscle revealed abnormally low phospho
rylation potentials for all these patients, although the degree of abn
ormality was variable and not directly correlated with the amount of b
rain lactate. It is proposed that cerebral dysgenesis and cerebral lac
tic acidemia as shown by magnetic resonance imaging and proton magneti
c resonance spectroscopy are useful diagnostic clues to PDHC deficienc
y, particularly in females in whom variable patterns of X-inactivation
reduce sensitivity of laboratory diagnosis based on the biochemical s
tudies of peripheral: tissues. In addition, muscle bioenergetic abnorm
alities in conjunction with CNS dysfunction may contribute to profound
hypotonia in this disorder.